A review on bevacizumab and surgical wound healing: an important warning to all surgeons.
about
Breast reconstruction following conservative mastectomies: predictors of complications and outcomesFactors That Impair Wound HealingMultisciplinary management of patients with liver metastasis from colorectal cancerDrug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.Safety of endoscopy in cancer patients on antiangiogenic agents: A retrospective multicenter outcomes study.Multidisciplinary approach of colorectal cancer liver metastases.Repeated bevacizumab injections versus mitomycin C in rotational conjunctival flap for prevention of pterygium recurrence.Biological agents in gastrointestinal cancers: adverse effects and their management.Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy.A prospective model of care for breast cancer rehabilitation: postoperative and postreconstructive issues.Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapyUse of bevacizumab as a first-line treatment for metastatic breast cancer.The effect of intravitreal anti-VEGF agents on peripheral wound healing in a rabbit modelBevacizumab-related osteonecrosis of the mandible is a self-limiting disease process.Major surgery in patients with metastatic colorectal cancer in Western europeA randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patientsThe effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healingRole of bevacizumab in colorectal cancer growth and its adverse effects: a review.Evidence for the role of bevacizumab in the treatment of advanced metastatic breast cancer: a review.Serum levels of intravitreal bevacizumab after vitrectomy, lensectomy and non-surgical controls.GROWTH FACTORS AND COX2 IN WOUND HEALING: AN EXPERIMENTAL STUDY WITH EHRLICH TUMORS.Surgical treatment of primary breast cancer in the neoadjuvant setting.Prophylactic plastic surgery closure of neurosurgical scalp incisions reduces the incidence of wound complications in previously-operated patients treated with bevacizumab (Avastin®) and radiation.Systematic review of the risk of adverse outcomes associated with vascular endothelial growth factor inhibitors for the treatment of cancer.Morbidity of the abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).Complications of intravitreal injections in patients with diabetes.The Neurostimulation Appropriateness Consensus Committee (NACC) Recommendations for Infection Prevention and Management.Hepatic artery dissection in a patient on bevacizumab resulting in pseudoaneurysm formation.The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer.Wound healing complications in brain tumor patients on Bevacizumab.Post-incisional ventral hernia repair in patients undergoing chemotherapy: improving outcomes with biological mesh.Chemotherapy does not adversely impact outcome following post-incisional hernia repair with biomaterial mesh.Anti-VEGF Agents and Glaucoma Filtering Surgery.Post-trabeculectomy topical bevacizumab preventing bleb failure: a preliminary study.E2F1 Hinders Skin Wound Healing by Repressing Vascular Endothelial Growth Factor (VEGF) Expression, Neovascularization, and Macrophage Recruitment.Anti-Angiogenic Drugs: Involvement in Cutaneous Side Effects and Wound-Healing Complication.Does neoadjuvant bevacizumab increase surgical complications in breast surgery?The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction.Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients.
P2860
Q26773601-0AE31750-3F25-4A5D-AF4D-ED42299F4F5DQ26995854-EAB0B43D-780C-4EC8-A815-8D31A2C03942Q28069575-2CC41DF8-E242-49CB-B164-699ADC08BCC2Q30616602-983AF4C8-A44C-4705-BF73-D3B8ACCB5E7FQ33637887-56D21382-774B-42A8-8F83-1423B99E2757Q33779859-9ECEEB3E-A573-43D3-8C9F-FC23AF883C1EQ33780646-50368B9A-921E-435F-B19E-602A7B7615D1Q33895581-8E89E32D-608A-4F9E-A01C-33868D9A8283Q34097998-52BA26B1-2EF5-4530-8DD9-0135EBFE74A8Q34266953-CA7B05BE-9DFB-4B4C-8F71-D4B02B91534EQ35284618-7B2E7B04-2069-4196-97D9-8BFF2DD38700Q35445151-C79E5A07-C4A4-44B5-9FE6-D34B19E20DA1Q35682039-4CC3A921-DC0E-4CB9-BB15-9F5FAB96B50FQ35978414-B29D5193-E145-482B-A1A9-208FF4D93A99Q36183424-6826BD78-DD0C-4115-8DC7-B6336E8981CCQ36508375-76F2F654-7DF8-454C-888E-76A6532729AEQ36574090-8F06ABFD-302B-4972-9235-9BD6D50A9984Q37102447-519A6FC2-3CFE-4C54-86EC-C6611A026AFCQ37355708-BB3753CA-248D-42E2-94A3-25DA5D2B2E7BQ37455178-3B7DE137-2954-4F9F-823F-A12104C6727FQ37579476-6E21BF63-AB4C-4461-A782-33906839E298Q38212607-B2CDBCC0-757F-4B07-99D5-084B141E2B9DQ38215707-2ECC7577-E052-4488-8E12-433176548DABQ38225636-0EAC9400-F1CC-4F61-8F95-BD764E8B709CQ38253190-691F8C43-9385-4E7E-9221-BF05742698ACQ38261106-BDC02EE1-ECB6-4132-8E91-A2756849A4E3Q38434080-8D0482E2-DC80-480A-B119-734AE24299E6Q38704849-30348686-A36C-42D2-82B6-E7B248ED3D6CQ38810865-4CBEE9B2-9F85-44D2-B85C-61F2620F69CCQ40616500-7BA0148F-CB5A-4491-993B-2C357FE5597CQ41348418-C81CD746-FACF-4E09-A337-BB65EDCCA8EBQ41549729-315318D6-61B0-4CCF-83C9-DAAFB5AD3071Q41998998-51065FFD-4BC0-4691-9ED2-81AD84521292Q42206872-8489A57E-9B01-4C7D-8314-C729204B213AQ42380731-54AAC41F-FB10-405B-A76C-6A84B90428D5Q42926957-714AF106-F1DF-4737-A0F8-24433FFD46B3Q43430943-CCC864EA-786A-4520-B16E-23763B64F864Q45047438-2988F8E4-0674-451E-BD5F-1A63BAE57B59Q45142013-99598344-041B-4F07-A1CF-032679C08E39Q47346411-2929D11A-7D81-415B-A6E5-016B4F470561
P2860
A review on bevacizumab and surgical wound healing: an important warning to all surgeons.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review on bevacizumab and surgical wound healing: an important warning to all surgeons.
@en
A review on bevacizumab and surgical wound healing: an important warning to all surgeons.
@nl
type
label
A review on bevacizumab and surgical wound healing: an important warning to all surgeons.
@en
A review on bevacizumab and surgical wound healing: an important warning to all surgeons.
@nl
prefLabel
A review on bevacizumab and surgical wound healing: an important warning to all surgeons.
@en
A review on bevacizumab and surgical wound healing: an important warning to all surgeons.
@nl
P2093
P1476
A review on bevacizumab and surgical wound healing: an important warning to all surgeons.
@en
P2093
Brian Kann
Chad R Gordon
Generosa Grana
James E Zins
Mitul Patel
Robert Simons
Umar Atabek
Yuri Rojavin
P304
P356
10.1097/SAP.0B013E3181828141
P577
2009-06-01T00:00:00Z